Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The emerging roles of exosomal long non-coding RNAs in bladder cancer. | J Cell Mol Med | 2022 | 34981655 | PubTator, text mining | PubMed |
| Correction to: Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA. | Mol Cancer | 2022 | 34980130 | PubTator, text mining | PubMed |
| A novel imatinib-upregulated long noncoding RNA plays a critical role in inhibition of tumor growth induced by Abl oncogenes. | Mol Cancer | 2022 | 34980123 | PubTator, text mining | PubMed |
| Long non-coding RNA MAGI2-AS3 inactivates STAT3 pathway to inhibit prostate cancer cell proliferation via acting as a microRNA-424-5p sponge. | J Cancer | 2022 | 34976194 | PubTator, text mining | PubMed |
| LncRNA UCA1 mediates Cetuximab resistance in Colorectal Cancer via the MiR-495 and HGF/c-MET Pathways. | J Cancer | 2022 | 34976187 | PubTator, text mining | PubMed |
| The roles of long non-coding RNAs in lung cancer. | J Cancer | 2022 | 34976181 | PubTator, text mining | PubMed |
| Long non-coding RNA DCST1-AS1/hsa-miR-582-5p/HMGB1 axis regulates colorectal cancer progression. | Bioengineered | 2022 | 34967274 | PubTator, text mining | PubMed |
| Exosomes: Small vesicles with big roles in cancer, vaccine development, and therapeutics. | Bioact Mater | 2022 | 34901546 | PubTator, text mining | PubMed |
| LncRNA UCA1, miR-26a, and miR-195 in coronary heart disease patients: Correlation with stenosis degree, cholesterol levels, inflammatory cytokines, and cell adhesion molecules. | J Clin Lab Anal | 2022 | 34850451 | PubTator, text mining | PubMed |
| LncRNAWiki 2.0: a knowledgebase of human long non-coding RNAs with enhanced curation model and database system. | Nucleic Acids Res | 2022 | 34751395 | PubTator, text mining | PubMed |
| SNHG17, as an EMT-related lncRNA, promotes the expression of c-Myc by binding to c-Jun in esophageal squamous cell carcinoma. | Cancer Sci | 2022 | 34714590 | PubTator, text mining | PubMed |
| Dysregulated lncRNA and mRNA may promote the progression of ischemic stroke via immune and inflammatory pathways: results from RNA sequencing and bioinformatics analysis. | Genes Genomics | 2022 | 34699043 | PubTator, text mining | PubMed |
| Long non-coding RNA CTSLP8 mediates ovarian cancer progression and chemotherapy resistance by modulating cellular glycolysis and regulating c-Myc expression through PKM2. | Cell Biol Toxicol | 2022 | 34510316 | PubTator, text mining | PubMed |
| The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease. | Brain Pathol | 2022 | 34414627 | PubTator, text mining | PubMed |
| lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling. | Mol Ther | 2022 | 34371180 | PubTator, text mining | PubMed |
| The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma. | Mol Oncol | 2022 | 34080276 | PubTator, text mining | PubMed |
| LncRNA UCA1 promotes tumorigenesis of breast cancer via targeting MiR-185-5p. | Minerva Med | 2022 | 33319971 | PubTator, text mining | PubMed |
| Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer. | Semin Cancer Biol | 2022 | 33207266 | PubTator, text mining | PubMed |
| Molecular and cellular paradigms of multidrug resistance in cancer. | Cancer Rep (Hoboken) | 2022 | 33052041 | PubTator, text mining | PubMed |
| The role of YAP in the control of the metastatic potential of oral cancer. | Oncol Res | 2021 | 37304649 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=54